Pulmozyme is a prescription medicine indicated along with standard therapies, for the management of pediatric and adult patients with cystic fibrosis (CF) to improve lung function. It works by breaking …

Jul 30, 2024 · Pulmozyme is a synthetic protein that breaks down excess DNA in the pulmonary secretions of people with cystic fibrosis. Pulmozyme is used in people with cystic fibrosis to thin …

Feb 21, 2025 · Overview: Pulmozyme is an inhaled medicine for cystic fibrosis. It makes the mucus in your lungs thinner and easier to clear, which can help you breathe better. The most common side …

Feb 29, 2024 · Pulmozyme (Dornase alfa) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.

Feb 1, 2026 · Use the mouthpiece of the nebulizer to breathe in Pulmozyme®. Do not use a face mask with the nebulizer because less medicine will get into your lungs. Patients who are unable to breathe …

Dec 17, 2025 · PULMOZYME® is indicated, in conjunction with standard therapies, for the management of pediatric and adult patients with cystic fibrosis (CF) to improve pulmonary function.

The safety and effectiveness of PULMOZYME in conjunction with standard therapies for cystic fibrosis have been established in pediatric patients. Use of PULMOZYME in pediatric patients is supported …

NICE guideline on diagnosis and management of CF recommends offering Pulmozyme as the first choice of mucoactive agent to patients with CF who have clinical evidence of lung disease before …

Pulmozyme: Dornase alfa is a medication that is used in combination with other medications to treat cystic fibrosis. It is used to reduce the risk of respiratory tract infections (e.g., bronchitis, pneumonia) …

Pulmozyme works to break up thick and sticky mucus in the lungs of people with CF. Pulmozyme (dornase alfa) is indicated for daily administration in conjunction with standard therapies for the …